Latest receivables for TRHC: $39M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Tabula Rasa HealthCare (TRHC) currently reports a receivables of $39M as of June 2023. That compares with $58M in the prior-year period — down 33.0% year over year. Use the charts on this page to explore Tabula Rasa HealthCare's receivables history and peer comparisons.
Tabula Rasa HealthCare's receivables decreased from $58M to $39M — a 33.0% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Tabula Rasa HealthCare reported $39M in receivables as of June 2023. That compares with $58M in the prior-year period — down 33.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $39M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tabula Rasa HealthCare, and consider following TRHC for alerts when major investors trade the stock.
Tabula Rasa HealthCare is classified in the Consumer Staples sector. On receivables, it currently shows $39M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing TRHC with unrelated industries.